logo
Z02

Service project: Multiparametric analysis of lymphoma cells and their microenvironment

The overall aim of the CRC is to achieve progress in lymphoma therapy. Therefore, the members of the CRC aim to investigate key cellular mechanisms involved in B cell lymphomagenesis and therapy resistance, since these processes are complex. In order to support these aims, a central platform will be established for the multiparametric analysis of human and murine samples. It will provide cytometric, immunohistochemical, (epi-)genomic and proteomic analytics to all participants of the CRC to dissect the diversity of the malignant and non-malignant counterparts in lymphoid malignancies at bulk and single cell level by applying standardized protocols for the reproducible and reliable assessment and phenotyping of lymphoma. A close cooperation with the platform Z03 will allow to share, visualize, and inter-relate data.

PRINCIPAL INVESTIGATOR

Prof. Dr. med. Reinhard Büttner

Institute of Pathology

University Hospital of Cologne

Kerpener Straße 62 

50937 Cologne

 

Prof. Dr. med. Thomas Oellerich

Department of Medicine II

Hematology/Oncology

University Hospital Frankfurt

Theodor-Stern-Kai 7

60590 Frankfurt am Main

Dr. rer. nat. Nieves Peltzer

Department of Translational Genomics

CMMC - Center for Molecular Medicine Cologne

University of Cologne

Robert-Koch-Straße 21

50931 Cologne

 

University of Cologne

Weyertal 115b

50931 Cologne

Dr. med. Lukas Frenzel

Apoptosis-Signaling and Therapy Resistance Group

Department I of Internal Medicine

University Hospital of Cologne

Kerpener Straße 62 

50937 Cologne

Prof. Dr. med. Dr. rer. nat. Michal Schweiger

Institute for Translational Epigenetics

University of Cologne

Weyertal 115b

50931 Cologne

 

 

 

Project Interactions